Krzysztof Jeziorski

Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial

J. Randolph Hecht, Yung‐Jue Bang, Shukui Qin et al. · Journal of Clinical Oncology · 2015 · 611 citations · Full text

Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study

Krzysztof Bujko, Lucjan Wyrwicz, Andrzej Rutkowski et al. · Annals of Oncology · 2016 · 432 citations · Full text

Radiation Therapy, Gastrointestinal Oncology, Medicine +9

Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin

Robert G. Gish, Camillo Porta, Lucian Lazar et al. · Journal of Clinical Oncology · 2007 · 279 citations

Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study

A Sankowski, Nina Seklecka, John Buscombe et al. · Annals of Oncology · 2009 · 170 citations

Medicine, Radionuclide Therapy, Phase Ii Study +8

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial

Michel Ducreux, Eric Van Cutsem, Jean‐Luc Van Laethem et al. · European Journal of Cancer · 2005 · 128 citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +9